Literature DB >> 4762057

Plasma kinetics of methaqualone in man after single oral doses.

G Alván, J E Lindgren, C Bogentoft, O Ericsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4762057     DOI： 10.1007/bf00558284

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  [SUBSTITUTED 4-QUINAZOLINONE DERIVATIVES AS HYPNOTICS AND ANTICONVULSANTS].

Authors:  K H BOLTZE; H D DELL; H LEHWALD; D LORENZ; M RUEBERG-SCHWEER
Journal:  Arzneimittelforschung       Date:  1963-08

2.  Plasma levels and absorption of methaqualone after oral administration to man.

Authors:  R N Morris; G A Gunderson; S W Babcock; J F Zaroslinski
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

3.  An improved quantitative gas-liquid chromatographic assay for the estimation of methaqualone in biological fluids.

Authors:  M Mitchard; M E Williams
Journal:  J Chromatogr       Date:  1972-10-05

4.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

5.  Mass fragmentography and elemental analysis by means of a new and combined multiple ion detector--peak matcher device. Developments of new techniques in gas chromatography-mass spectrometry.

Authors:  C G Hammar
Journal:  Acta Pharm Suec       Date:  1971-06
  5 in total
  11 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.

Authors:  C White; E Doyle; L F Chasseaud; T Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

4.  Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.

Authors:  G Alván; O Ericsson; S Levander; J E Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

5.  Long-term urinary excretion of methaqualone in a human subject.

Authors:  H D Heck; K Maloney; M Anbar
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

Authors:  M Oram; K Wilson; D Burnett; S G Al-Dabbagh; J R Idle; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.

Authors:  K Wilson; C N Reynolds; D Burnett
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

8.  Behavioural sequelae of methaqualone in man and in the monkey (Macaca mulatta).

Authors:  R G Borland; A N Nicholson; C M Wright
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 9.  An assessment of short-acting hypnotics.

Authors:  W B Mendelson; B Jain
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

10.  Hexapropymate self-poisoning causes severe and long-lasting clinical symptoms.

Authors:  L L Gustafsson; A Berg; A Magnusson; H O Malmlund; B M Sandell; R Stig
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.